These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action. Fetherston SM; Boyd P; McCoy CF; McBride MC; Edwards KL; Ampofo S; Malcolm RK Eur J Pharm Sci; 2013 Feb; 48(3):406-15. PubMed ID: 23266465 [TBL] [Abstract][Full Text] [Related]
9. Characterization of silicone elastomer vaginal rings containing HIV microbicide TMC120 by Raman spectroscopy. Bell SE; Dennis AC; Fido LA; Malcolm RK; Sirimuthu NM; Toner CF; Woolfson AD J Pharm Pharmacol; 2007 Feb; 59(2):203-7. PubMed ID: 17270074 [TBL] [Abstract][Full Text] [Related]
10. Development of a multi-layered vaginal tablet containing dapivirine, levonorgestrel and acyclovir for use as a multipurpose prevention technology. McConville C; Major I; Devlin B; Brimer A Eur J Pharm Biopharm; 2016 Jul; 104():171-9. PubMed ID: 27163243 [TBL] [Abstract][Full Text] [Related]
11. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response. Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746 [TBL] [Abstract][Full Text] [Related]
12. A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy. Ugaonkar SR; Wesenberg A; Wilk J; Seidor S; Mizenina O; Kizima L; Rodriguez A; Zhang S; Levendosky K; Kenney J; Aravantinou M; Derby N; Grasperge B; Gettie A; Blanchard J; Kumar N; Roberts K; Robbiani M; Fernández-Romero JA; Zydowsky TM J Control Release; 2015 Sep; 213():57-68. PubMed ID: 26091920 [TBL] [Abstract][Full Text] [Related]
13. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide. Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869 [TBL] [Abstract][Full Text] [Related]
14. Transient analysis of drug delivery from a toroidal membrane: Applications for medicated vaginal rings. Simon L; Ospina J Eur J Pharm Sci; 2020 Jan; 141():105114. PubMed ID: 31655211 [TBL] [Abstract][Full Text] [Related]
15. [Preparation and release mechanism of gestodene reservoir-type intravaginal rings]. Li CX; Wang YK; Ning MY Yao Xue Xue Bao; 2014 Mar; 49(3):399-405. PubMed ID: 24961114 [TBL] [Abstract][Full Text] [Related]
16. A dynamic mechanical method for determining the silicone elastomer solubility of drugs and pharmaceutical excipients in silicone intravaginal drug delivery rings. Malcolm RK; McCullagh S; Woolfson AD; Catney M; Tallon P Biomaterials; 2002 Sep; 23(17):3589-94. PubMed ID: 12109683 [TBL] [Abstract][Full Text] [Related]
17. Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings. Malcolm RK; Woolfson AD; Toner CF; Morrow RJ; McCullagh SD J Antimicrob Chemother; 2005 Nov; 56(5):954-6. PubMed ID: 16155060 [TBL] [Abstract][Full Text] [Related]
19. Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy. Clark JT; Clark MR; Shelke NB; Johnson TJ; Smith EM; Andreasen AK; Nebeker JS; Fabian J; Friend DR; Kiser PF PLoS One; 2014; 9(3):e88509. PubMed ID: 24599325 [TBL] [Abstract][Full Text] [Related]
20. Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir. Murphy DJ; Desjardins D; Dereuddre-Bosquet N; Brochard P; Perrot L; Pruvost A; Le Grand R; Lagatie O; Vanhooren L; Feyaerts M; van Roey J; Malcolm RK J Antimicrob Chemother; 2014 Sep; 69(9):2477-88. PubMed ID: 24862093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]